Although we accommodate APOE status and CSF biomarker levels in our analysis, we did not specifically stratify our subjects based on amyloid positivity, under the emerging concept that amyloid facilitates rather than governs the spatiotemporal trajectory of Alzheimer’s disease spectrum subjects. Here, APOE is linked to Alzheimer disease.